Associate Professor, Obstetrics and Gynecology, Brown University Program in Medicine
Obstetrics & Gynecology
Dr. Paul Disilvestro, MD
|
|
Give Review
Paul Disilvestro practices Obstetrics & Gynecology. He researched medicine at University of Vermont College of Medicine. He received 2 awards: "Regional Top Doctor" and "Fellow (FACOG)". Doctor Paul Disilvestro, MD has written publications. He has 40 publications published with PubMed. The lastest publication is: 'Prognostic value of clinical variables in ovarian cancer.' He is registered with Medicare.
Publications
- A phase I trial of pegylated liposomal doxorubicin (PLD), carboplatin, bevacizumab and veliparib in recurrent, platinum-sensitive Ovarian, primary peritoneal, and fall...
- Assessing the risk of ovarian malignancy algorithm for the conservative management of women with a Pelvic mass.
- Combined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncolo...
- Pathologic Findings at Risk-Reducing Salpingo-Oophorectomy: Primary Results From Gynecologic Oncology Group Trial GOG-0199.
- Long-term follow-up of vulvar Cancer patients evaluated with sentinel lymph node biopsy alone.
- A phase II evaluation of pazopanib in the treatment of recurrent or persistent carcinosarcoma of the uterus: A Gynecologic Oncology Group study.
- Phase III Randomized Trial of Weekly Cisplatin and Irradiation Versus Cisplatin and Tirapazamine and Irradiation in Stages IB2, IIA, IIB, IIIB, and IVA Cervical Carcin...
- A phase II evaluation of AMG 102 (rilotumumab) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal Carcinoma: A Gyneco...
- 36. Anal cytology and HPV genotyping in women With lower genital tract neoplasia.
- Oral thalidomide as palliative chemotherapy in women with advanced ovarian Cancer.
- A randomized controlled trial of a regular diet as the first meal in gynecologic oncology patients undergoing intraabdominal surgery.
- Comparison of tolerance of combination carboplatin and paclitaxel chemotherapy by age in women with ovarian Cancer.
- Outcomes of endometrial Cancer patients undergoing surgery with gynecologic oncology involvement.
- Phase II trial of trastuzumab in women with advanced or recurrent, HER2-positive endometrial Carcinoma: a Gynecologic Oncology Group study.
- Phase II study of carboplatin, paclitaxel, and bevacizumab With maintenance bevacizumab as first-line chemotherapy for advanced mullerian tumors.
- Addressing clinical trials: can the multidisciplinary Tumor Board improve participation? A study from an academic women's Cancer program.
- Pilot phase 2 trial of 4 months of maintenance pegylated liposomal Doxorubicin in patients with advanced ovarian Cancer after complete response to platinum and Paclita...
- Radiation therapy with concomitant paclitaxel and cisplatin chemotherapy in cervical Carcinoma limited to the pelvis: a phase I/II study of the Gynecologic Oncology Gr...
- Treatment of Cervical intraepithelial neoplasia levels 2 and 3 with adapalene, a retinoid-related molecule.
- Evaluation of the diagnostic accuracy of the risk of ovarian malignancy algorithm in women with a Pelvic mass.
- Panniculectomy in morbidly obese gynecologic oncology patients.
- Cross-sensitivity between paclitaxel and docetaxel in a women's Cancers program.
- Two for good measure: six versus eight cycles of carboplatin and paclitaxel as adjuvant treatment for epithelial ovarian Cancer.
- Malignant mixed mesodermal tumors of the ovary.
- 'You may think I'm too old, but can't you treat my Cancer?'.
- Ovarian Cancer? What is the next step?
- Lower uterine segment involvement as a predictor for lymph node spread in endometrial Carcinoma.
- The use of multiple novel tumor biomarkers for the detection of ovarian Carcinoma in patients with a pelvic mass.
- Isolated sentinel lymph node dissection with conservative management in patients with squamous cell Carcinoma of the vulva: a prospective trial.
- For women receiving chemotherapy for clinically apparent early ovarian Cancer, is there a benefit to surgical staging?
- A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian Cancer in patients with a pelvic mass.
- Urinary symptoms and impact on quality of life in women after treatment for endometrial Cancer.
- A phase I/II study of extended field radiation therapy with concomitant paclitaxel and cisplatin chemotherapy in patients with cervical Carcinoma metastatic to the par...
- Phase II trial of ixabepilone as second-line treatment in advanced endometrial Cancer: gynecologic oncology group trial 129-P.
- Stage IV small bowel Carcinoma mimicking advanced ovarian cancer.
- [Proposal of the biological monitoring of inhalation anesthetics].
- Prognostic value of clinical variables in ovarian Cancer.
- The prognostic significance of lower uterine segment involvement in surgically staged endometrial Cancer patients with negative nodes.
- Willingness of gynecologic Cancer patients to participate in clinical trials.
Schools
University Of Vermont College Of Medicine
Rhode Island Hospital
Brow UWomen and Infants Hospital
University Okla Health Science Center
Procedures Preformed
- Colpopexy
- Colporrhaphy
- Colposcopy
- Destruction or Excision of Lesion of Cervix (incl. LEEP)
- View All
Conditions Treated
- Carcinoma in Situ
- Cervical Cancer
- Cervical Polyps
- Cervicitis
- View All
Doctors Specialties
- Gynecologic Oncology
- Obstetrics
- Gynecology
Accepted Insurances
Awards
- Regional Top Doctor
- Fellow (FACOG)
Education
-
University of Oklahoma Health Sciences Center -
University of Vermont College of Medicine
Drug Facts
| NPI NUMBER | 1174559603 | |
| NPPES Provider LastName | DISILVESTRO | |
| NPPES Provider FirstName | PAUL | |
| NPPES Provider ZIPCode | 029052401 | |
| NPPES Provider State | RI | |
| Specialty Description | Gynecological/Oncology | |
| Total Claim Count | 74.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1174559603 |
| Last Name Of The Provider | DISILVESTRO |
| First Name Of The Provider | PAUL |
| View All |
Similar Doctors
|
|
Dr. Ashley Stuckey, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marcia M. Schmidt, MD |
|
|
Dr. Maureen S. Hamel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Katina M. Robison, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael A. Steller, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Donald A. Ramos, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stephen S. Falkenberry, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dario Roque, MD |
|
|
Dr. Roxanne Vrees, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph T. Demartino, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Altug Koymen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John J. Bert, MD
This Doctor is OpenDoctor Recommended.
|